Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma.
靶向富含亮氨酸重复激酶 2 可克服胶质母细胞瘤对溶瘤性单纯疱疹病毒疗法的耐药性。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-70132-9
Qin Yaning, Liang Zhiqi, Yu Mengqin, Lin Nanqian, Wang Naizhen, Huang Xuanke, Chen Shi, Peng Qun, Lin Yanhua, Wang Heqin, Rao Yipeng, Xu Zilong, Huang Shenghua, Cai Jingjing, Li Yukui, Zhang Jun, Lin Chaolong, Tan Guowei, Xia Ningshao, Huang Chenghao
